Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,253 | -12,202 | 10,223 | 492 | 10,049 |
| Depreciation Amortization | 765 | 264 | -1,206 | 99 | 57 |
| Accounts receivable | 163 | 39 | -395 | 9 | -89 |
| Accounts payable and accrued liabilities | -181 | 2 | 1,521 | 936 | 611 |
| Other Working Capital | -3,141 | -4,269 | 10,479 | 679 | 209 |
| Other Operating Activity | 4,600 | 2,101 | 7,171 | 5,025 | 3,331 |
| Operating Cash Flow | $-24,047 | $-14,065 | $27,793 | $7,240 | $14,168 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,350 | -18,435 | -96,095 | N/A | N/A |
| PPE Investments | -447 | -18 | -1,285 | -194 | -194 |
| Investing Cash Flow | $-8,797 | $-18,453 | $-97,380 | $-194 | $-194 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,144 | 300 | 45,629 | 44,868 | 45,021 |
| Common Stock Repurchased | N/A | N/A | -370 | N/A | N/A |
| Other Financing Activity | 181 | 0 | 162 | 0 | 0 |
| Financing Cash Flow | $9,325 | $300 | $45,421 | $44,868 | $45,021 |
| Beginning Cash Position | 61,446 | 61,446 | 85,612 | 85,612 | 85,612 |
| End Cash Position | 37,927 | 29,228 | 61,446 | 137,526 | 144,607 |
| Net Cash Flow | $-23,519 | $-32,218 | $-24,166 | $51,914 | $58,995 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,047 | -14,065 | 27,793 | 7,240 | 14,168 |
| Capital Expenditure | -447 | -18 | -1,285 | -194 | -194 |
| Free Cash Flow | -24,494 | -14,083 | 26,508 | 7,046 | 13,974 |